Christopher Lucasti

Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections

G. Ralph Corey, Heidi Kabler, Purvi Mehra et al. · New England Journal of Medicine · 2014 · 302 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

Christopher Lucasti, Irinel Popescu, M Ramesh et al. · Journal of Antimicrobial Chemotherapy · 2013 · 234 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Mark H. Wilcox, G. Ralph Corey, George H. Talbot et al. · Journal of Antimicrobial Chemotherapy · 2010 · 215 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection

Christopher Lucasti, Liviu Vasile, Dorel Săndesc et al. · Antimicrobial Agents and Chemotherapy · 2016 · 181 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Ertapenem Once Daily Versus Piperacillin‐Tazobactam 4 Times per Day for Treatment of Complicated Skin and Skin‐Structure Infections in Adults: Results of a Prospective, Randomized, Double‐Blind Multicenter Study

Donald R. Graham, Christopher Lucasti, Osvaldo Malafaia et al. · Clinical Infectious Diseases · 2002 · 130 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15